Abstract:
The present invention addresses an ongoing need in the art to improve the stability of immunogenic compositions such as polysaccharide-protein conjugates and protein immunogens. The invention broadly relates to novel formulations which stabilize and inhibit precipitation of immunogenic compositions. More particularly, the invention described hereinafter, addresses a need in the art for formulations which stabilize and inhibit particulate formation (e.g., aggregation, precipitation) of immunogenic compositions which are processed, developed, formulated, manufactured and/or stored in container means such as fermentors, bioreactors, vials, flasks, bags, syringes, rubber stoppers, tubing and the like.
Abstract:
A system for minimizing downtime in an appliance-based business continuance architecture is provided. The system includes at least one primary data storage and least one primary host machine. The system includes an intercept agent to intercept primary host machine data requests, and to collect information associated with the intercepted data requests. Moreover, at least one business continuance appliance in communication with the primary host machine and in communication with a remote backup site is provided. The appliance receives information associated with the intercepted data requests from the intercept agent. In addition, a local cache is included within the business continuance appliance. The local cache maintains copies of primary data storage according to the information received. Furthermore, the remote site is provided with the intercepted data requests via the business continuance appliance, wherein the remote site maintains a backup of the primary data storage.
Abstract:
An apparatus and method to replicate one or more files between non-symmetric storage systems are disclosed. The method supplies a first storage system comprising a first configuration, a first volume, a first file system, and a first replication appliance comprising first replication appliance memory. The method further supplies a second storage system comprising a second configuration, a second volume, a second file system, and a second replication appliance comprising second replication appliance memory, where the first configuration differs from the second configuration. The first storage system receives a dataset, writes that dataset to the first volume as a first file. Applicants' method then replicates the first file to the second volume as a second file, and maintains in the second replication appliance memory a second replication appliance mapping associating the first file with the second file.
Abstract:
Described herein are antipyschotic compounds of formula (I) wherein, A is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, O, and S; Alk is (C1-4) alkylene optionally substituted with OH, methoxy, ethoxy, or F; Ar is optionally substituted phenyl, naphthyl, monocyclic heteroaromatic, or bicyclic heteroaromatic; R1 is hydrogen or (C1-4) alkyl optionally substituted with OH, OR3, or OCH2CH2OH, wherein R3 is (C1-2) alkyl; R2 is H, (C1-6) alkyl, halogen, fluorinated (C1-6) alkyl, OR4, SR4, NO2, CN, COR4, CONR5R6, SO2NR5R6, NR5R6, NR5COR4, NR5SO2R4, or optionally substituted phenyl, wherein R4 is hydrogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, or optionally substituted phenyl, R5 and R6 are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl; Z is one or two substituents independently selected from hydrogen, halogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, OR7, SR7, NO2, CN, COR7, CONR8R9, SO2NR8R9, NR8SO2R7, NR8R9, or optionally substituted phenyl, wherein R7 is hydrogen, (C1-6) alkyl, fluorinated alkyl, or optionally substituted phenyl, R8 and R9 are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl; and salts, solvates, and crystal forms thereof. Also described are the use of the compounds of formula (I) as antagonists of the dopamine D2 receptor and as agents for the treatment of psychosis and bipolar disorder, and pharmaceutical formulations of the compounds of formula (I).
Abstract:
Embodiments herein present a method for a back-tracking decision tree classifier for a large reference data set. The method analyzes first data files having a higher usage than second data files and identifies file attribute sets that are common in the first data files. Next, the method associates associated qualifiers with each of the file attribute sets, wherein each of the associated qualifiers represents a corresponding first data file. The associated qualifiers are then counted to determine the number of associated qualifiers that are associated with each of the file attribute sets. Subsequently, the file attribute sets are sorted in descending order based on the number of associated qualifiers. The counting and sorting are initially performed on file attribute sets that only have a single file attribute.
Abstract:
Neural degeneration is reduced in a patient determined to be suffering from chronic neurodegeneration by administering to the patient an effective amount of 3-pyridinecarboxamide (nicotinamide) and detecting a resultant decrease in the neural degeneration.
Abstract:
Systems, methods, and computer products that improve the techniques used to search multidimensional databases over techniques of the past. The preferred embodiment of the present invention advantageously improves the technique of determining a grid index that is used to locate a geometric shape in a spatial database. More particularly, the preferred embodiment of the present invention improves the technique of sampling data for defining the grid cell size in a grid for a given data set, thereby improving the grid indexing process that locates a particular minimum-bounding rectangle and the associated geometric shape.
Abstract:
Described herein are antipyschotic compounds of formula (I) wherein, A is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, O, and S; Alk is (C1-4) alkylene optionally substituted with OH, methoxy, ethoxy, or F; Ar is optionally substituted phenyl, naphthyl, monocyclic heteroaromatic, or bicyclic heteroaromatic; R1 is hydrogen or (C1-4) alkyl optionally substituted with OH, OR3, or OCH2CH2OH, wherein R3 is (C1-2) alkyl; R2 is H, (C1-6) alkyl, halogen, fluorinated (C1-6) alkyl, OR4, SR4, NO2, CN, COR4, CONR5R6, SO2NR5R6, NR5R6, NR5COR4, NR5SO2R4, or optionally substituted phenyl, wherein R4 is hydrogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, benzyl, or optionally substituted phenyl, R5 and R6 are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl; Z is one or two substituents independently selected from hydrogen, halogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, OR7, SR7, NO2, CN, COR7, CONR8R9, SO2NR8R9, NR8SO2R7, NR8R9, or optionally substituted phenyl, wherein R7 is hydrogen, (C1-6) alkyl, fluorinated alkyl, benzyl, or optionally substituted phenyl, R8 and R9 are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl; and salts, solvates, and crystal forms thereof. Also described are the use of the compounds of formula (a) as antagonists of the dopamine D2 receptor and as agents for the treatment of psychosis and bipolar disorders, and pharmaceutical formulations of the compounds of formula (I). Also described are compounds useful as intermediates for the synthesis of the compounds of formula (I).
Abstract:
Provides point label placement determining methods, apparatus and systems. A point label placement determining method and system are used in map browsing service based on session mode. In an example embodiment, initial label placement data in a scale is calculated by a static point label determining method. When a user requires a map browsing service, the requirement are met by using an incremental label placement method on the base of said initial label placement data. The incremental point label placement method dramatically reduces the cost for service process. Therefore, the simultaneous requirements of a large number of users can be met. The present invention is successfully used in location based service systems.
Abstract:
Novel methods of synthesizing heteroatom-containing chiral porphyrins and chiral metalloporphyrins and the novel chiral porphyrins and chiral metalloporphyrins themselves are disclosed. Metal complexes of the chiral porphyrins are prepared in high yields and shown to be active catalysts for highly enantioselective and diastereoselective cyclopropanation, aziridination, and epoxidation of alkenes under a practical one-pot protocol.